Drug Des Devel Ther. 2025 Jan 6;19:65-66. doi: 10.2147/DDDT.S512114. eCollection 2025.
NO ABSTRACT
PMID:39803608 | PMC:PMC11721147 | DOI:10.2147/DDDT.S512114
Categories
Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]
